03:25 PM EDT, 03/13/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price by $10 to $215, valuing MMC shares at 23.0x our 2025 adjusted EPS estimate of $9.35 (trimmed by $0.10) and at 25.3x our 2024 EPS estimate of $8.50 (lowered by $0.10), versus the shares' one-year average forward multiple of 23x and the insurance brokerage peer average of 21.4x. We forecast revenue growth of 8%-12% in 2024 and 2025, on still-favorable commercial lines insurance pricing and demand trends. Revenues in 2023 rose 10% (versus our forecast of a 10%-12% rise). We believe this market leading global provider of risk management, strategy, and human capital consulting services is well positioned to leverage an increased demand for risk transfer services. We also think recent cost cutting steps will aid margins. But, at current levels, these positive factors are already reflected in the shares' valuation.